Welcome to the Radboudumc what are you looking for?
A Dutch research team from Radboud University Medical Center has visualized the injection of radioactive microspheres during treatment of a patient with liver tumors ‘live on screen’.
Aiosyn, a spin-off from Radboudumc, has received an investment from LUMO Labs. Oost NL is a co-investor.
Tom Scheenen has been appointed Professor of Biomedical Magnetic Resonance at the Radboudumc / Radboud University as of 1 October 2021.
This website uses cookies. Read more about cookies.